Chi Mei Hospital was approved by the Taiwan FDA for treating patients with “Stage IV solid cancer'' by autologous dendritic cell therapy on February 19, 2020

Chi Mei Hospital was approved by the Taiwan FDA for treating patients with “Stage IV solid cancer'' by autologous dendritic cell therapy on February 19, 2020

"Chi Mei Hospital" is one of the Ever Supremes’ collaborating medical institutes. It received approval by the Taiwan FDA for treating patients with "Stage 4 Solid Cancer" by autologous dendritic cells (DC) on February 19, 2020.   Patients qualified to be admitted for relevant treatment include the following indications: glioblastoma multiforme and secondary brain cancer, epithelial ovarian cancer, pancreatic cancer, prostate cancer, head and neck cancer , Liver cancer, breast cancer, and colorectal cancer.

BACK